๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Compound trial record
Trackers Drugs Trial finder
Compound · clinical trials

Colchicine Pill clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — the 2 trials in our China register that name Colchicine Pill as an intervention. Synced 25 Sep 2026
2Current trials
1Recruiting now
1Lead sponsor
1Country register
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 โ€” Top 14 finalist
Compiled from ClinicalTrials.gov registry records ยท Last verified ยท Editorial standards
At a glance

Colchicine Pill is named as an intervention in 2 current clinical trials in our China register. 1 is recruiting patients now. All registered phases are Not applicable. The lead sponsor is Beijing Anzhen Hospital. The most-studied condition is CAD - Coronary Artery Disease.

Trials by status

  • Recruiting150%
  • Not yet open150%

Trials by phase

  • Not applicable2100%
01

Clinical trials of Colchicine Pill

2 trials
StudyPhaseStatusLead sponsorRegisters
Treatment of ACuTe Coronary Syndromes With Low-dose colchICine
NCT06215989 · ClinicalTrials.gov ↗ · Acute Coronary Syndrome, Unstable Angina, ST Elevation Myocardial Infarction
Not applicable Recruiting Beijing Anzhen Hospital China
Low-dose Colchicine for CABG Graft Failure Prevention
NCT07569328 · ClinicalTrials.gov ↗ · CAD - Coronary Artery Disease, CABG, Colchicine
Not applicable Not yet open Beijing Anzhen Hospital China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.

02

Conditions studied with Colchicine Pill

7 conditions
CAD - Coronary Artery Disease1CABG1Colchicine1Acute Coronary Syndrome1Unstable Angina1ST Elevation Myocardial Infarction1Non ST Segment Elevation Myocardial Infarction1
03

Sponsors

lead sponsor per trial
Lead sponsorTrials
Beijing Anzhen Hospital2
04

By country register

RegisterTrialsRecruiting
Clinical trials in China21

A trial with sites in more than one country appears in each of those registers.

05

Questions about Colchicine Pill trials

How many clinical trials are testing Colchicine Pill?

2 current trials in our China register name Colchicine Pill as a drug or biological intervention, as of the registry sync on 25 September 2026. Completed and withdrawn studies are not counted.

Are Colchicine Pill trials recruiting patients?

Yes. 1 of the 2 trials is recruiting: 1 with sites in China. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Who sponsors Colchicine Pill clinical trials?

The lead sponsor is Beijing Anzhen Hospital. The number in brackets is how many trials each organisation leads.

Where does this information come from?

Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Colchicine Pill works or whether it is effective, and it is not medical advice.

How this page is built

Everything on this page is copied from public ClinicalTrials.gov registry records โ€” it is not written from memory, and nothing here describes how Colchicine Pill works or whether it is effective. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Colchicine Pill (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 25 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician โ€” our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us โ€” we correct promptly and log it.